Literature DB >> 27708970

Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.

Martha Adriana Badillo-Soto1, Mayra Rodríguez-Rodríguez1, María Elena Pérez-Pérez1, Leonel Daza-Benitez2, Juan José Bollain-Y-Goytia1, Miguel Angel Carrillo-Jiménez3, Esperanza Avalos-Díaz1, Rafael Herrera-Esparza1.   

Abstract

OBJECTIVE: The molecular mechanism of citrullination involves the calcium-dependent peptidylarginine deiminase (PAD) family of enzymes. These enzymes induce a stereochemical modification of normal proteins and transform them into autoantigens, which in rheumatoid arthritis trigger a complex cascade of joint inflammatory events followed by chronic synovitis, pannus formation, and finally, cartilage destruction. By hypothesizing that PAD2 and PAD4 enzymes produce autoantigens, we investigated five possible synovial protein targets of PAD enzymes.
MATERIAL AND METHODS: We measured PAD2, PAD4, and citrullinated proteins in 10 rheumatoid and 10 osteoarthritis synovial biopsies and then assessed the post-translational modifications of fibrinogen, cytokeratin, tubulin, IgG, and vimentin proteins using a double-fluorescence assay with specific antibodies and an affinity-purified anti-citrullinated peptide (CCP) antibody. The degree of co-localization was analyzed, and statistical significance was determined by ANOVA, Fisher's exact test, and regression analysis.
RESULTS: The principal results of this study demonstrated that citrullinated proteins, such as fibrinogen, IgG, and other probed proteins, were targets of PAD2 and PAD4 activity in rheumatoid synovial biopsies, whereas osteoarthritis biopsies were negative for this enzyme (p<0.0001). An analysis of citrullination sites using the UniProtKB/Swiss-Prot data bank predicts that the secondary structure of the analyzed proteins displays most of the sites for citrullination; a discussion regarding its possible meaning in terms of pathogenesis is made.
CONCLUSION: Our results support the conclusion that the synovial citrullination of proteins is PAD2 and PAD4 dependent. Furthermore, there is a collection of candidate proteins that can be citrullinated.

Entities:  

Keywords:  Peptidylarginine deiminase 2; peptidylarginine deiminase 4; rheumatoid arthritis; synovial membrane

Year:  2016        PMID: 27708970      PMCID: PMC5042229          DOI: 10.5152/eurjrheum.2015.0055

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  42 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

2.  Fast events in protein folding: relaxation dynamics of secondary and tertiary structure in native apomyoglobin.

Authors:  R Gilmanshin; S Williams; R H Callender; W H Woodruff; R B Dyer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva.

Authors:  G P Harvey; T R Fitzsimmons; A A S S K Dhamarpatni; C Marchant; D R Haynes; P M Bartold
Journal:  J Periodontal Res       Date:  2012-09-16       Impact factor: 4.419

4.  Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity.

Authors:  Leen De Rycke; Anthony P Nicholas; Tineke Cantaert; Elli Kruithof; Joshua D Echols; Bart Vandekerckhove; Eric M Veys; Filip De Keyser; Dominique Baeten
Journal:  Arthritis Rheum       Date:  2005-08

Review 5.  Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis.

Authors:  Erik R Vossenaar; Walther J van Venrooij
Journal:  Arthritis Res Ther       Date:  2004-04-19       Impact factor: 5.156

6.  Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity.

Authors:  Erika Darrah; Jon T Giles; Michelle L Ols; Herbert G Bull; Felipe Andrade; Antony Rosen
Journal:  Sci Transl Med       Date:  2013-05-22       Impact factor: 17.956

7.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

8.  Novel multiplex technology for diagnostic characterization of rheumatoid arthritis.

Authors:  Piyanka E Chandra; Jeremy Sokolove; Berthold G Hipp; Tamsin M Lindstrom; James T Elder; John D Reveille; Heike Eberl; Ursula Klause; William H Robinson
Journal:  Arthritis Res Ther       Date:  2011-06-24       Impact factor: 5.156

Review 9.  Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity.

Authors:  Annette H M van der Helm-van Mil; Ferdinand C Breedveld; Tom W J Huizinga
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.

Authors:  Vincent Goëb; Marlène Thomas-L'Otellier; Romain Daveau; Roland Charlionet; Patrice Fardellone; Xavier Le Loët; François Tron; Danièle Gilbert; Olivier Vittecoq
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

View more
  8 in total

1.  Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.

Authors:  Xue Li; Zhenni Wang; Han Yi; Jun Xie; Naishuo Zhu
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

2.  Technical comment on "Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis".

Authors:  A J Salinger; M L Dubuke; C Carmona-Rivera; A J Maurais; S A Shaffer; E Weerapana; P R Thompson; M J Kaplan
Journal:  Sci Immunol       Date:  2020-01-31

3.  Carbamylation/citrullination of IgG Fc in bronchiectasis, established RA with bronchiectasis and RA smokers: a potential risk factor for disease.

Authors:  David Hutchinson; Alexander Clarke; Kate Heesom; Daniel Murphy; Paul Eggleton
Journal:  ERJ Open Res       Date:  2017-09-19

4.  Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.

Authors:  Dan Murphy; Derek Mattey; David Hutchinson
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

Review 5.  Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects.

Authors:  Jiaxi Liu; Jinfang Gao; Zewen Wu; Liangyu Mi; Na Li; Yajing Wang; Xinyue Peng; Ke Xu; Fengping Wu; Liyun Zhang
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 6.  The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Chih-Wei Liu; Cheng-Hsun Lu; Hsien-Tzung Liao; Ming-Han Chen; Ko-Jen Li; Cheng-Han Wu; Cheih-Yu Shen; Yu-Min Kuo; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 7.  Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer's disease.

Authors:  Ingar Olsen; Sim K Singhrao; Jan Potempa
Journal:  J Oral Microbiol       Date:  2018-06-22       Impact factor: 5.474

8.  Identification and Characterization of the Lactating Mouse Mammary Gland Citrullinome.

Authors:  Guangyuan Li; Coleman H Young; Bryce Snow; Amanda O Christensen; M Kristen Demoruelle; Venkatesh V Nemmara; Paul R Thompson; Heather M Rothfuss; Brian D Cherrington
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.